Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 31, 2024Frontiers in OncologyOpen Access

Imaging response to immune checkpoint inhibitors in patients with advanced melanoma: a retrospective observational cohort study

View Full Paper
Ask AI
Bookmark
Share

Authors

MGMehul GuptaUniversity of CalgaryISIgor StukalinUniversity of CalgaryDMDaniel E. MeyersCancerCare Manitoba

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gupta et al. (2024) studied this question.

synapsesocial.com/papers/68e6763ab6db643587600dcchttps://doi.org/10.3389/fonc.2024.1385425
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pembrolizumab versus Ipilimumab in Advanced Melanoma2015 · 6,000 citations
  2. 2Prognostic factors for survival in melanoma patients with brain metastases2010 · 558 citations
  3. 3Clinical Models to Define Response and Survival With Anti–PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma2022 · 88 citations
  4. 4Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma2021 · 1,149 citations